myLaurel: Pioneering Home-Based Healthcare with $12M Boost
June 13, 2025, 3:30 pm
In a world where healthcare is often synonymous with long waits and sterile hospital rooms, myLaurel is flipping the script. This New York City-based healthcare company has just secured $12 million in funding, a lifeline that will help it expand its innovative home-based acute and transitional care services. The funding round was led by Deerfield Management and GV, with notable participation from Emerson Collective, Pinta Partners, and Ochsner Health.
The urgency for change in healthcare is palpable. With an aging population and looming hospital bed shortages projected by 2032, the traditional model of emergency room visits and lengthy hospital stays is buckling under pressure. Costs are soaring, and patient satisfaction is dwindling. Enter myLaurel, a company that aims to deliver high-quality care directly to patients' homes, alleviating the burden on overwhelmed hospital systems.
myLaurel's approach is simple yet revolutionary. It provides on-demand acute and transitional care to frail, elderly, or medically complex patients, allowing them to sidestep the traditional care path that often leads to emergency rooms and hospital admissions. By leveraging advanced technology and remote physician guidance, myLaurel is reshaping the healthcare landscape.
The company’s flagship program, Acute Care at Home, has already demonstrated impressive results. It boasts a 33% reduction in emergency department utilization, a 49% decrease in readmissions, and saves hospitals over 3,000 bed days annually. These metrics are not just numbers; they represent lives improved and systems relieved.
myLaurel operates through three core care models: Rapid Advanced Care™, Acute Care at Home™, and Recovery at Home™. Each model is designed to tackle specific challenges within the healthcare system. Rapid Advanced Care™ focuses on preventing unnecessary hospital visits by providing immediate in-home care. Acute Care at Home™ facilitates earlier discharges from hospitals, while Recovery at Home™ helps manage patients post-hospitalization to prevent readmissions.
The inspiration behind myLaurel is deeply personal. CEO Juan Vallarino's experience with his father's repeated emergency room visits ignited a passion for change. He recognized the emotional and physical toll that traditional care paths can take on patients and their families. This realization became the bedrock of myLaurel's mission: to provide a more patient-centered, effective, and efficient model of care.
What sets myLaurel apart is its commitment to outcomes. The company partners with hospitals and health systems, putting its fees at risk if patients under its care require hospitalization for the same or related conditions. This innovative model aligns incentives and underscores myLaurel's dedication to delivering measurable results.
The market for myLaurel's services is vast. It primarily targets health systems and risk-bearing organizations, addressing critical operational pain points such as reducing length of stay and improving patient throughput. As healthcare shifts towards home-based care, myLaurel is positioned to capture a significant share of this multibillion-dollar opportunity.
The recent funding will propel myLaurel into its next growth phase. Plans include increasing patient volume in existing markets like New York and Louisiana, deepening partnerships with current clients, and launching new collaborations with health systems in additional markets. The company is also focused on building a top-tier clinical team to ensure high-quality, scalable care.
As the economic landscape shifts, myLaurel's focus on high-acuity, medically complex patients makes its services resilient. Even in downturns, demand for home-based care remains steady. The company’s model not only reduces overall healthcare costs but also provides financial relief to health systems and payers grappling with budget constraints.
Investors are taking notice. The backing from Deerfield and GV highlights the confidence in myLaurel's ability to deliver real, measurable value. By shifting care to the most appropriate setting—the home—myLaurel is generating strong returns on investment for its partners. This compelling business model, combined with proven outcomes and growing demand, makes myLaurel a beacon of hope in the healthcare sector.
Looking ahead, myLaurel is poised for significant expansion. The company aims to enhance its service offerings and deepen its market presence, all while maintaining its commitment to patient-centered care. The next six months will be crucial as myLaurel seeks to solidify its position as a leader in home-based healthcare.
In a time when the healthcare system is in dire need of innovation, myLaurel stands at the forefront. With its recent funding, the company is not just aiming to grow; it is on a mission to redefine how care is delivered. The future of healthcare may very well be at home, and myLaurel is leading the charge.
As we navigate this evolving landscape, one thing is clear: myLaurel is not just a company; it is a movement towards a more compassionate, efficient, and effective healthcare system. The journey has just begun, and the possibilities are limitless.
The urgency for change in healthcare is palpable. With an aging population and looming hospital bed shortages projected by 2032, the traditional model of emergency room visits and lengthy hospital stays is buckling under pressure. Costs are soaring, and patient satisfaction is dwindling. Enter myLaurel, a company that aims to deliver high-quality care directly to patients' homes, alleviating the burden on overwhelmed hospital systems.
myLaurel's approach is simple yet revolutionary. It provides on-demand acute and transitional care to frail, elderly, or medically complex patients, allowing them to sidestep the traditional care path that often leads to emergency rooms and hospital admissions. By leveraging advanced technology and remote physician guidance, myLaurel is reshaping the healthcare landscape.
The company’s flagship program, Acute Care at Home, has already demonstrated impressive results. It boasts a 33% reduction in emergency department utilization, a 49% decrease in readmissions, and saves hospitals over 3,000 bed days annually. These metrics are not just numbers; they represent lives improved and systems relieved.
myLaurel operates through three core care models: Rapid Advanced Care™, Acute Care at Home™, and Recovery at Home™. Each model is designed to tackle specific challenges within the healthcare system. Rapid Advanced Care™ focuses on preventing unnecessary hospital visits by providing immediate in-home care. Acute Care at Home™ facilitates earlier discharges from hospitals, while Recovery at Home™ helps manage patients post-hospitalization to prevent readmissions.
The inspiration behind myLaurel is deeply personal. CEO Juan Vallarino's experience with his father's repeated emergency room visits ignited a passion for change. He recognized the emotional and physical toll that traditional care paths can take on patients and their families. This realization became the bedrock of myLaurel's mission: to provide a more patient-centered, effective, and efficient model of care.
What sets myLaurel apart is its commitment to outcomes. The company partners with hospitals and health systems, putting its fees at risk if patients under its care require hospitalization for the same or related conditions. This innovative model aligns incentives and underscores myLaurel's dedication to delivering measurable results.
The market for myLaurel's services is vast. It primarily targets health systems and risk-bearing organizations, addressing critical operational pain points such as reducing length of stay and improving patient throughput. As healthcare shifts towards home-based care, myLaurel is positioned to capture a significant share of this multibillion-dollar opportunity.
The recent funding will propel myLaurel into its next growth phase. Plans include increasing patient volume in existing markets like New York and Louisiana, deepening partnerships with current clients, and launching new collaborations with health systems in additional markets. The company is also focused on building a top-tier clinical team to ensure high-quality, scalable care.
As the economic landscape shifts, myLaurel's focus on high-acuity, medically complex patients makes its services resilient. Even in downturns, demand for home-based care remains steady. The company’s model not only reduces overall healthcare costs but also provides financial relief to health systems and payers grappling with budget constraints.
Investors are taking notice. The backing from Deerfield and GV highlights the confidence in myLaurel's ability to deliver real, measurable value. By shifting care to the most appropriate setting—the home—myLaurel is generating strong returns on investment for its partners. This compelling business model, combined with proven outcomes and growing demand, makes myLaurel a beacon of hope in the healthcare sector.
Looking ahead, myLaurel is poised for significant expansion. The company aims to enhance its service offerings and deepen its market presence, all while maintaining its commitment to patient-centered care. The next six months will be crucial as myLaurel seeks to solidify its position as a leader in home-based healthcare.
In a time when the healthcare system is in dire need of innovation, myLaurel stands at the forefront. With its recent funding, the company is not just aiming to grow; it is on a mission to redefine how care is delivered. The future of healthcare may very well be at home, and myLaurel is leading the charge.
As we navigate this evolving landscape, one thing is clear: myLaurel is not just a company; it is a movement towards a more compassionate, efficient, and effective healthcare system. The journey has just begun, and the possibilities are limitless.